alizarin complexone structure
|
Common Name | alizarin complexone | ||
---|---|---|---|---|
CAS Number | 3952-78-1 | Molecular Weight | 385.324 | |
Density | 1.6±0.1 g/cm3 | Boiling Point | 687.1±55.0 °C at 760 mmHg | |
Molecular Formula | C19H15NO8 | Melting Point | ~185 °C (dec.) | |
MSDS | Chinese USA | Flash Point | 369.4±31.5 °C |
Use of alizarin complexoneAlizarin complexone is a calcium-tracer and a chelating agent. Alizarin complexone is Rous-associated virus 2 reverse transcriptase (RAV-2 RT) inhibitor[1][2]. |
Name | alizarin complexone |
---|---|
Synonym | More Synonyms |
Description | Alizarin complexone is a calcium-tracer and a chelating agent. Alizarin complexone is Rous-associated virus 2 reverse transcriptase (RAV-2 RT) inhibitor[1][2]. |
---|---|
Related Catalog | |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 687.1±55.0 °C at 760 mmHg |
Melting Point | ~185 °C (dec.) |
Molecular Formula | C19H15NO8 |
Molecular Weight | 385.324 |
Flash Point | 369.4±31.5 °C |
Exact Mass | 385.079773 |
PSA | 152.44000 |
LogP | 3.38 |
Vapour Pressure | 0.0±2.2 mmHg at 25°C |
Index of Refraction | 1.720 |
Stability | Incompatible with strong oxidizing agents. |
Water Solubility | Slightly soluble (0.2 g/L) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
~% alizarin complexone CAS#:3952-78-1 |
Literature: Belcher et al. Journal of the Chemical Society, 1958 , p. 2390,2392 |
Precursor 3 | |
---|---|
DownStream 0 |
HS Code | 2922509090 |
---|---|
Summary | 2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
[Histochemical staining methods for lanthanum].
Rinsho Byori. 59(9) , 844-51, (2011) In recent years lanthanum compounds have been widely used in the optical and electronic industries. Although release of lanthanum (La) into the environment and exposure to humans are feared, acute or ... |
|
Isometric Scaling in Developing Long Bones Is Achieved by an Optimal Epiphyseal Growth Balance.
PLoS Biol. 13 , e1002212, (2015) One of the major challenges that developing organs face is scaling, that is, the adjustment of physical proportions during the massive increase in size. Although organ scaling is fundamental for devel... |
|
Prostate cancer cells preferentially home to osteoblast-rich areas in the early stages of bone metastasis: evidence from in vivo models.
J. Bone Miner Res. 29(12) , 2688-96, (2014) It has been suggested that metastasis-initiating cells gain a foothold in bone by homing to a metastastatic microenvironment (or "niche"). Whereas the precise nature of this niche remains to be establ... |
2-[carboxymethyl-[(3,4-dihydroxy-9,10-dioxoanthracen-2-yl)methyl]amino]acetic acid |
Alizarin-3-methylimino-N,N-diacetic Acid |
Glycine, N-(carboxymethyl)-N-[(9,10-dihydro-3,4-dihydroxy-9,10-dioxo-2-anthracenyl)methyl]- |
Alizarin-3-methyliminodiacetic acid |
3,4-Dihydroxyanthraquinon-2-yl-methylimino-diacetic acid |
EINECS 223-544-2 |
MFCD00001202 |
Alizarin complexone |
1,2-Dihydroxyanthraquinonyl-3-methylamine-N,N-diacetic Acid |
2,2'-{[(3,4-Dihydroxy-9,10-dioxo-9,10-dihydro-2-anthracenyl)methyl]imino}diacetic acid |
2,2'-{[(3,4-Dihydroxy-9,10-dioxo-9,10-dihydroanthracen-2-yl)methyl]imino}diacetic acid |
Alizarin Fluorine Blue |